Tamara Isakova
Overview
Explore the profile of Tamara Isakova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
160
Citations
8200
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Culler K, Zelnick L, Mehta R, de Sosa G, Kansal M, Rao P, et al.
Heart
. 2025 Feb;
PMID: 39915070
Background: Intercellular adhesion molecule-1 (ICAM-1) is a cell-surface protein that facilitates inflammation through leucocyte adhesion. Approximately 35% of Black individuals carry at least one copy of an missense variant (rs5491;...
2.
Ketteler M, Evenepoel P, Holden R, Isakova T, Jorgensen H, Komaba H, et al.
Kidney Int
. 2025 Jan;
107(3):405-423.
PMID: 39864017
In 2017, Kidney Disease: Improving Global Outcomes (KDIGO) published a Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Since...
3.
Jain K, Katz R, Isakova T, Kizer J, Sharma S, Psaty B, et al.
Kidney360
. 2024 Nov;
PMID: 39560998
Background: Elevated levels of fibroblast growth factor 23 (FGF23) are associated with left ventricular hypertrophy and heart failure (HF) in individuals with and without kidney disease. Prior studies investigated the...
4.
Scialla J, Mallawaarachchi I, Illenberger N, Brookhart M, Isakova T, Mitra N, et al.
Am J Epidemiol
. 2024 Aug;
PMID: 39198916
Epidemiologic studies have identified many biochemical risk factors for chronic kidney disease (CKD) progression that are correlates of kidney function, termed here 'CKD-associated physiologic factors'. Uncertainty remains if these factors...
5.
Tian L, Jaeger B, Scialla J, Budoff M, Mehta R, Jaar B, et al.
Am J Kidney Dis
. 2024 Aug;
85(1):67-77.e1.
PMID: 39154888
Rationale & Objective: Coronary artery calcification (CAC) progresses rapidly in people with chronic kidney disease (CKD) compared with the general population. We studied the association between CAC progression and higher...
6.
Edmonston D, Fuchs M, Burke E, Isakova T, Wolf M
Am J Kidney Dis
. 2024 Apr;
84(3):349-360.e1.
PMID: 38583756
Rationale & Objective: Klotho deficiency may affect clinical outcomes in chronic kidney disease (CKD) through fibroblast growth factor-23 (FGF23)-dependent and -independent pathways. However, the association between circulating Klotho and clinical...
7.
Trujillo J, Alotaibi M, Seif N, Cai X, Larive B, Gassman J, et al.
Kidney360
. 2024 Apr;
5(5):681-689.
PMID: 38570905
No abstract available.
8.
Gonzales K, Koch-Weser S, Kennefick K, Lynch M, Porteny T, Tighiouart H, et al.
J Am Soc Nephrol
. 2024 Mar;
35(6):772-781.
PMID: 38517479
No abstract available.
9.
Sohn M, Gao B, Kendrick C, Srivastava A, Isakova T, Gassman J, et al.
Kidney Int Rep
. 2024 Mar;
9(3):671-685.
PMID: 38481512
Introduction: Disruption of gut microbiota underpins some of the metabolic alterations observed in chronic kidney disease (CKD). Methods: In a nonrandomized, open-label, 3-phase pilot trial, with repeated measures within each...
10.
Hsu S, Bansal N, Denburg M, Ginsberg C, Hoofnagle A, Isakova T, et al.
J Bone Miner Res
. 2024 Mar;
39(4):433-442.
PMID: 38477777
Fracture risk is high in chronic kidney disease (CKD) and underlying pathophysiology and risk factors may differ from the general population. In a cohort study of 3939 participants in the...